Biotech / MedTech
Amgen and NSG Biolabs announce golden ticket to boost Singapore’s Biotech Ecosystem
As part of the sponsorship, Amgen will support one "Golden Ticket" award each year for three years, providing winners with one year of free residency in NSG Biolabs’ fully equipped turnkey BSL-2 laboratory as well as additional facility benefits and connections to Amgen's scientific and business leaders.
Singapore biotech firm Nalagenetics raises $12.6M Series A funding co-led by Intudo Ventures and Vulcan Capital
Nalagenetics announced Friday the closing of a $12.6 million Series A round of financing co-led by Intudo Ventures and Vulcan Capital. The round also saw participation from strategic investors, including Singapore-based Diagnostics Development Hub (DxD Hub) through the Agency for Science, Technology and Research’s (A*STAR) A*ccelerate Technologies Pte Ltd,…
Malaysian biotechnology firm GK Aqua seeks to raise $478,000 to $1.91M via ECF Platform pitchIN
GK Aqua Sdn Bhd, a Malaysian Biotechnology company is looking to raise a minimum of MYR2 million ($478,000) for 4.26 percent equity with a maximum target of MYR8 million ($1.91 million) for 15.09 percent equity via the Malaysian equity crowdfunding platform pitchIN.
Israel’s MeMed raises $93M to accelerate commercialization of its host immune-response product portfolio
MeMed announced Monday a $93 million private financing round, bringing total funding in the company to over $200 million, including support from the U.S. Department of Defense and EU Commission. The funds will be used to scale up manufacturing, accelerate commercialization and expand MeMed’s pioneering host immune response product portfolio, The latest…
Hong Kong unicorn Prenetics to tap vast opportunities in Southeast Asia amid global expansion
Prenetics, which is expected to go public on the Nasdaq in the first quarter of next year, is also actively looking for local partners in Southeast Asia.
Singapore biotech startup RWDC Industries raises $95.1M in Series B2 funding co-led by Vickers Venture Partners and Temasek
RWDC Industries Limited announced the closing of a $95.1 million Series B2 funding round co-led by Singapore venture capital firm Vickers Venture Partners and Singapore state investor Temasek. The funding will support the group’s expansion and boost its production of biodegradable biopolymer material that will help the group speed adoption of sustainable…
Singapore BioTech TurtleTree raises $30M Series A funding led by European investor VERSO Capital
Turtle Tree has successfully raised $30 million in the first tranche of its Series A funding, one of the largest investment rounds to date in Asia's cell-based food sector. The funding sees participation from investors worldwide, including lead investor VERSO Capital. Following this round of funding, TurtleTree has now raised over US$40 million to date.
MiRXES secures $77M Series C funding to accelerate multi-cancer early detection pipeline
Led by CR-CP Life Science Fund, this new capital will support MiRXES’s growth as a global leader in cancer early detection tests and preventive healthcare.
Insilico Medicine closes $255M Series C led by Warburg Pincus to further develop AI and drug discovery
Proceeds from the funding will be used to progress Insilico Medicine's current therapeutic programs into human clinical trials, initiate multiple new programs for novel and difficult targets, and further develop its AI and drug discovery capabilities, the company added.
